Gastrointestinal Motility Disorders Correlate with Intracranial Bleeding, Opioid Use, and Brainstem Edema in Neurosurgical Patients

被引:3
|
作者
Kunovac, Franka [1 ]
Cicvaric, Ana [1 ,2 ]
Robba, Chiara [3 ]
Turk, Tajana [1 ,4 ]
Muzevic, Dario [1 ,5 ]
Kralik, Kristina [1 ]
Kvolik, Slavica [1 ,2 ]
机构
[1] Univ Osijek, Fac Med, Osijek, Croatia
[2] Univ Hosp Osijek, Dept Anesthesiol, Resuscitat & Intens Care Unit, Osijek, Croatia
[3] IRCCS Oncol & Neurosci, Policlin San Martino, Anesthesia & Intens Care, Genoa, Italy
[4] Univ Hosp Osijek, Dept Radiol, J Huttlera 4, Osijek 31000, Croatia
[5] Univ Hosp Osijek, Dept Neurosurg, J Huttlera 4, Osijek, Croatia
关键词
Acute brain injury; Brainstem edema; Gastrointestinal motility; Gastric emptying; Parasympathetic dysfunction; Intracranial hemorrhages; Analgesics; Opioid; Intensive care unit; Mechanical ventilation; PAROXYSMAL SYMPATHETIC HYPERACTIVITY; CRITICALLY-ILL PATIENTS; INJURY; DYSMOTILITY; DYSFUNCTION;
D O I
10.1007/s12028-023-01678-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundGastrointestinal (GI) motility disorders may be directly associated with the intensity of acute brain injury, edema of the brainstem, and opioid use in neurosurgical patients.MethodsIn this retrospective study, patient demographic characteristics, computed tomography (CT) scans, the occurrence of gastroparesis, constipation, and opioid use were registered during the intensive care unit (ICU) stay and correlated with days of mechanical ventilation, length of ICU stay, and survival. Gastroparesis was defined as residual gastric volume > 250 mL per day, and constipation was defined as the absence of stool for 3 days or more during the ICU stay.ResultsOf 207 neurosurgical patients screened, 69 adult patients who spent more than 4 days in the ICU were included in the study. Gastroparesis was observed in 48 (69.6%) patients, constipation was observed in 67 (97.1%) patients, and stress ulcers were observed in 4 (5.8%) patients. Patients with brainstem edema (n = 57, 82.6%) had the first stool evacuation later compared with patients with no edema (8 [interquartile range (IQR) 5.25-9.75] vs. 3.5 [IQR 2.25-4] days; P < 0.001). In the logistic regression analysis, factors that were associated with GI dysmotility were central nervous system (CNS) bleeding (odds ratio [OR] 5.1, 95% confidence interval [CI] 1.26-20.8, P = 0.02), opioid use > 19.3 morphine equivalents (ME) per day (OR 5.37, 95% CI 1.1-27.1, P = 0.04), and brainstem edema (OR 4.9, 95% CI 1.1-21.6, P = 0.04). A receiver operating characteristic curve analysis confirmed that the cutoff value of > 6.78 ME per day was a good predictor determining GI dysmotility, with 89.5% sensitivity and 72.7% specificity (95% CI 0.67-0.88, area under the curve 0.784, Youden index 0.62, P = 0.001). Poor survival correlated with lower Glasgow Coma Score values (rho = - 520, P < 0.001), CNS bleeding (rho = 0.393, P < 0.001), associated cardiac diseases (rho = 0.279, P < 0.001), and cardiorespiratory arrest on admission (rho = 0.315, P < 0.001), but not with GI dysmotility (rho = 0.175, P = 0.402).ConclusionsSignificant correlation was registered between brainstem edema, gastrointestinal dysmotility, and opioids. CNS bleeding was the most important single factor influencing GI dysmotility. Further studies with opioid and nonopioid sedation may distinguish the influence of acute brain lesions versus drugs on GI dysmotility.
引用
收藏
页码:368 / 377
页数:10
相关论文
共 50 条
  • [1] Gastrointestinal Motility Disorders Correlate with Intracranial Bleeding, Opioid Use, and Brainstem Edema in Neurosurgical Patients
    Franka Kunovac
    Ana Cicvaric
    Chiara Robba
    Tajana Turk
    Dario Muzevic
    Kristina Kralik
    Slavica Kvolik
    Neurocritical Care, 2023, 39 : 368 - 377
  • [2] Opioid antagonists in the treatment of gastrointestinal motility disorders
    Meissner, W
    Schreiber, I
    Karzai, W
    Hartmann, M
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2003, 44 (12): : 825 - +
  • [3] Selective use of octreotide in gastrointestinal motility disorders
    Mousa, HM
    Hayes, J
    Dershem, E
    PEDIATRIC RESEARCH, 2002, 51 (04) : 142A - 142A
  • [4] Younger age at intracranial aneurysms rupture among patients with opioid use disorders
    Unda, Santiago R.
    Antoniazzi, Aldana M.
    Ramos, Rafael de la Garza
    Osborn, Irene
    Haranhalli, Neil
    Altschul, David J.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 94 : 204 - 208
  • [5] Incidence of Gastrointestinal Motility Disorders in Trauma Patients
    Virani, Farrukh R.
    Peery, Travis
    Rivas, Orlyn
    Holcomb, John B.
    Wade, Charles E.
    Uray, Karen
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : E199 - E200
  • [6] Gastrointestinal Motility Disorders in Critically Ill Patients
    Grajecki, Donata
    Tacke, Frank
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (11) : 696 - 703
  • [7] The use of botulinum toxin for the treatment of gastrointestinal motility disorders
    Friedenberg, F
    Gollamudi, S
    Parkman, HP
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (02) : 165 - 175
  • [8] ESTIMATION OF OPIOID USE FOR THE MANAGEMENT OF PAIN AMONG PATIENTS WITH CHRONIC GASTROINTESTINAL DISORDERS
    Lim, Jean J.
    Taylor, Douglas C.
    Higgins, Carolyn S.
    GASTROENTEROLOGY, 2019, 156 (06) : S577 - S578
  • [9] Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders
    Parthasarathy, G.
    Ravi, K.
    Camilleri, M.
    Andrews, C.
    Szarka, L. A.
    Low, P. A.
    Zinsmeister, A. R.
    Bharucha, A. E.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (12): : 1736 - 1746
  • [10] Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma
    Agostino Di Ciaula
    Michele Covelli
    Massimo Berardino
    David QH Wang
    Giovanni Lapadula
    Giuseppe Palasciano
    Piero Portincasa
    BMC Gastroenterology, 8